Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Tourani

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|March 1, 1990
Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemoimmunotherapy of metastatic malignant melanoma. The Salpétrière Hospital (SOMPS) experienceD Khayat, E Antoine, O Rixe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanomaD Khayat, C Borel, J M Tourani, et al.
Clinical Immunology and Immunopathology|May 1, 1988
Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseJ M Andrieu, P Even, A Venet, et al.
European Journal of Haematology|October 1, 1987
Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumorsS Roithmann, M Toledano, J M Tourani, et al.
British Journal of Cancer|November 23, 2006
The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progressionA Ferru, G Fromont, H Gibelin, et al.
Cancer Research|June 15, 1992
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinomaJ Y Blay, S Negrier, V Combaret, et al.
Clinical and Experimental Immunology|July 1, 1988
Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsetsJ M Andrieu, D Eme, A Venet, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|March 1, 1990
Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Chemoimmunotherapy of metastatic malignant melanoma. The Salpétrière Hospital (SOMPS) experienceD Khayat, E Antoine, O Rixe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanomaD Khayat, C Borel, J M Tourani, et al.
Clinical Immunology and Immunopathology|May 1, 1988
Effects of cyclosporin on T-cell subsets in human immunodeficiency virus diseaseJ M Andrieu, P Even, A Venet, et al.
European Journal of Haematology|October 1, 1987
Hodgkin's disease, clinical stages IA to IIIB: combined modality therapy (3 MOPP followed by curative and prophylactic radiotherapy including the spleen). Six-year resultsP Colonna, J M Andrieu, R Ghouadni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-associated tumorsS Roithmann, M Toledano, J M Tourani, et al.
British Journal of Cancer|November 23, 2006
The status of CDKN2A alpha (p16INK4A) and beta (p14ARF) transcripts in thyroid tumour progressionA Ferru, G Fromont, H Gibelin, et al.
Cancer Research|June 15, 1992
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinomaJ Y Blay, S Negrier, V Combaret, et al.
Clinical and Experimental Immunology|July 1, 1988
Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsetsJ M Andrieu, D Eme, A Venet, et al.
Pageof 7